Correlation Between Novacyt and Eurobio Scientific

Can any of the company-specific risk be diversified away by investing in both Novacyt and Eurobio Scientific at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novacyt and Eurobio Scientific into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novacyt and Eurobio Scientific SA, you can compare the effects of market volatilities on Novacyt and Eurobio Scientific and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novacyt with a short position of Eurobio Scientific. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novacyt and Eurobio Scientific.

Diversification Opportunities for Novacyt and Eurobio Scientific

-0.85

Correlation Coefficient

Novacyt  Eurobio Scientific

Pay attention - limited upside

The 3 months correlation between Novacyt and Eurobio is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Novacyt and Eurobio Scientific SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eurobio Scientific and Novacyt is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novacyt are associated (or correlated) with Eurobio Scientific. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eurobio Scientific has no effect on the direction of Novacyt i.e., Novacyt and Eurobio Scientific go up and down completely randomly.

Pair Corralation between Novacyt and Eurobio Scientific

Assuming the 90 days trading horizon Novacyt is expected to under-perform the Eurobio Scientific. In addition to that, Novacyt is 12.88 times more volatile than Eurobio Scientific SA. It trades about -0.16 of its total potential returns per unit of risk. Eurobio Scientific SA is currently generating about 0.13 per unit of volatility. If you would invest  2,485  in Eurobio Scientific SA on September 2, 2024 and sell it today you would earn a total of  80.00  from holding Eurobio Scientific SA or generate 3.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Novacyt  vs.  Eurobio Scientific SA

Novacyt

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novacyt has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Eurobio Scientific

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Eurobio Scientific SA are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Eurobio Scientific is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Novacyt and Eurobio Scientific

The main advantage of trading using opposite Novacyt and Eurobio Scientific positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novacyt position performs unexpectedly, Eurobio Scientific can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eurobio Scientific will offset losses from the drop in Eurobio Scientific's long position.

The idea behind Novacyt and Eurobio Scientific SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.